Reports of an outbreak of pneumonia cases among children in China have prompted the World Health Organisation (WHO) to ask for more details from the Chinese authorities, w
Innoviva has moved a step closer to bringing the first novel antibiotic to market for gonorrhoea in decades after reporting positive results in a phase 3 trial.
GSK has set its sights on dominance of the market for hepatitis B virus (HBV) therapeutics, licensing an antisense oligonucleotide drug from Arrowhead Pharma and Johnson &
The UK has launched a programme to try to accelerate the discovery and development of new diagnostics and treatments for antimicrobial-resistant (AMR) infections, backed w
Sanofi is paying $175 million upfront to claim a share of an experimental vaccine developed by Johnson & Johnson’s pharma unit Janssen that aims to tackle a major caus
